• Home
  • Search Results

Search Results

547 Results Found

  1. 10
  2. 20
  3. 30
  4. All
  • 2021 PLaNOVa™ EU VIRTUaL SYMPOSIUM

    We are pleased to invite you to join the upcoming 2021 Planova™ EU Virtual Symposium.
    With the present announcement, we are pleased to share confirmed Speakers of the event. The details of confirmed chairs and speakers can be found on the next page.
    Our distinguished speakers and users of Planova virus removal filters will share their experience of the downstream process development and the manufacturing of biopharmaceuticals. It will be a superb opportunity to gain new insights and learn about the state-of-the-art technology that can improve your processes. In addition to the presentations, you will be able to visit the exhibition hall with different booths. Our virtual platform enables you to chat not only with our global Planova team members, but also with other Planova users and key industry leaders.

  • asahi Kasei Medical to Double Production Capacity for Planova™ BioEX Filters

    asahi Kasei Medical Co., Ltd.
    asahi Kasei Medical has decided to expand production capacity of hydrophilic PVDF (polyvinylidene fluoride) hollow-fiber membranes for Planova™ BioEX filters at its spinning plant in Oita, Japan. The global COVID-19 pandemic has increased the urgent demand for Planova™ filters, which are indispensable to develop and mass-produce anti-coronavirus agents. asahi Kasei Medical will double spinning production capacity at this site by utilizing its state-of-the-art technology. The capacity increase is expected to commence in the fourth quarter of calendar year 2022.
    as for the Planova™ N series filters made with cellulose hollow-fiber membranes, all six existing plants, including the spinning plant completed in 2019 in Miyazaki, Japan, have been operating efficiently and without any disruption to meet the increasing demand worldwide.

  • about asahi Kasei Bioprocess

    about asahi Kasei Bioprocess
    Our Business OverviewOur Global NetworkOur History
    Pioneering Biologics Safety and Manufacturing Efficiency

  • Planova™ Seminar 2021 Russia

    The COVID-19 pandemic has led to a need for social distancing to help prevent the spread.
    Hereby we hope you can join us at Planova™ Seminar 2021 Russia on the rearranged date of
    Planova™ Seminar 2021 Russia

  • Save the Date: The 2021 Planova™ EU Virtual Symposium will take place on September 30 and October 1, 2021

    Hopefully, you and your families are healthy and safe during these uncertain and unprecedented times!
    The COVID-19 pandemic has caused an immense change to our daily lives and it also continues to define our new normal. This is a challenge we must overcome together in cooperation and mutual
    responsibility. Taking into account the health and safety of our customers and our staff, we recognized that organizing physical events is still too high of a risk.

  • Updated event details for 2021 Planova™ EU Virtual Symposium

    Further to our 1st announcement in april, we are pleased to give you more information on the upcoming Planova™ EU Virtual Symposium. We are delighted to announce the Chairs of the Virtual Symposium: Dr. Thomas R. Kreil, Dr. Salvador Grancha, Dr. Uwe Gottschalk, and Dr. Nathan J. Roth.
    It will be a superb opportunity to gain new insights and learn about the state-of-the-art technology that can improve your processes. In addition to the presentations, you will be able to visit the exhibition hall with different booths. Our virtual platform enables you to chat not only with our global Planova team members, but also with other Planova users and key industry leaders.
    We look forward to receiving your registration!

  • audit Reports

    Save time and cost of conducting a direct audit by utilizing audit reports available from an international supply chain consortium. asahi Kasei Bioprocess - Pioneering Biologics Safety and Manufacturing Efficiency.
    audit Reports availability
    audit reports for Planova Plant and Planova Oita Plant are now available for purchase from Rx-360, an international pharmaceutical supply chain consortium.